On one hand, DKC1 depletion in dyskeratosis congenita promoted cancer development through dysregulated translation, whereas on the other hand, elevated DKC1 expression could promote telomerase activity in some cancers [6]. The gene discussed is DKC1; the disease is dyskeratosis congenita.